Professor David Zarski
Project Finance
Professor Zarski is a member of Schuyler Roche Crisham in
Chicago, Illinois. In addition to managing $25-billion-plus
transactions, he has served as counsel to a wholly owned bank
subsidiary of a major retailer in a public offering of a credit card
receivable securitization exceeding $1-billion. He has served as
principal structuring counsel to the United States branch of a
large global bank and its associated commercial paper conduits
in various transactions. He holds a Juris Doctor degree from
DePaul University and is a member of the Illinois Bar.
Professor Joseph Hetrick
Crossborder Litigation
Professor Hetrick is a former partner at Dechert LLP. He defended
Philip Morris in tobacco litigation and represented Baxter
Healthcare in mass tort litigation throughout the world. He was
part of Dechert’s national defense team representing
GlaxoSmithKline in the Baycol litigation and worked in the Paxil
litigation in New Jersey and Pennsylvania. He played a central role
in litigation related to a painkiller for Merck & Co. and served as
trial counsel for Wyeth in the fen-phen litigation and has dealt with
product liability litigation for West Pharmaceutical, the York
International Corporation, the Stryker Corporation, and Airgas, Inc.
He holds a law degree from Temple University and is a member of
the Pennsylvania Bar.
Project Finance - Professor David Zarski
Professor
Zarski
is
a
member
of
Schuyler
Roche
Crisham
in
Chicago,
Illinois.
In
addition
to
managing
$25-billion-plus
transactions,
he
has
served
as
counsel
to
a
wholly
owned
bank
subsidiary
of
a
major
retailer
in
a
public
offering
of
a
credit
card
receivable
securitization
exceeding
$1-
billion.
He
has
served
as
principal
structuring
counsel
to
the
United
States
branch
of
a
large
global
bank
and
its
associated
commercial
paper
conduits
in
various
transactions.
He
holds
a
Juris
Doctor
degree
from
DePaul
University
and
is a member of the Illinois State Bar.
Crossborder
Litigation
-
Professor
Joseph
Hetrick
Professor
Hetrick
is
a
former
partner
at
Dechert
LLP.
He
defended
Philip
Morris
in
tobacco
litigation
and
represented
Baxter
Healthcare
in
mass
tort
litigation
throughout
the
world.
He
was
part
of
Dechert’s
national
defense
team
representing
GlaxoSmithKline
in
the
Baycol
litigation
and
worked
in
the
Paxil
litigation
in
New
Jersey
and
Pennsylvania.
He
played
a
central
role
in
litigation
related
to
a
painkiller
for
Merck
&
Co.
and
served
as
trial
counsel
for
Wyeth
in
the
fen-phen
litigation
and
dealt
with
product
liability
matters
for
West
Pharmaceutical,
York
International
Corporation,
Stryker
Corporation,
and
Airgas,
Inc.
He
holds
a
law
degree
from
Temple
University
and
is
a
member
of
the
Pennsylvania Bar.
